B
4.02
-0.18 (-4.29%)
| Previous Close | 4.20 |
| Open | 4.23 |
| Volume | 126,638 |
| Avg. Volume (3M) | 160,952 |
| Market Cap | 197,086,928 |
| Price / Earnings (TTM) | 6.93 |
| Price / Earnings (Forward) | 7.66 |
| Price / Sales | 0.600 |
| 52 Weeks Range | |
| Earnings Date | 6 Aug 2025 - 11 Aug 2025 |
| Profit Margin | 10.55% |
| Operating Margin (TTM) | 19.78% |
| Diluted EPS (TTM) | 0.580 |
| Quarterly Revenue Growth (YOY) | 4.70% |
| Quarterly Earnings Growth (YOY) | -52.10% |
| Current Ratio (MRQ) | 1.42 |
| Operating Cash Flow (TTM) | 44.34 M |
| Levered Free Cash Flow (TTM) | 54.17 M |
| Return on Assets (TTM) | 16.29% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Bearish |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Biote Corp. | Bearish | Bearish |
AIStockmoo Score
-0.5
| Analyst Consensus | -3.5 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 2.0 |
| Average | -0.50 |
|
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Value |
| % Held by Insiders | 13.02% |
| % Held by Institutions | 65.98% |
| 52 Weeks Range | ||
| Median | 4.00 (-0.50%) | |
| Total | 1 Hold | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| B. Riley Securities | 07 Aug 2025 | 4.00 (-0.50%) | Hold | 2.92 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 06 Aug 2025 | Announcement | Biote Reports Second Quarter 2025 Financial Results |
| 23 Jul 2025 | Announcement | Biote Schedules Second Quarter 2025 Financial Results Release and Conference Call |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |